ライフサイエンスコーパス: chronic rhinosinusitis

1 ave recently been associated with asthma and chronic rhinosinusitis.

2 llergy, in particular those of patients with chronic rhinosinusitis.

3 airway diseases, such as cystic fibrosis and chronic rhinosinusitis.

4 In patients with chronic rhinosinusitis, a novel endotyping approach pure

5 cated in nasal polyps (NPs) of patients with chronic rhinosinusitis and might play a significant role

6 cated in nasal polyps (NPs) of patients with chronic rhinosinusitis and might play a significant role

7 All of the patients had chronic rhinosinusitis and nasal polyposis, and these re

8 ver, the exact role of microbial biofilms in chronic rhinosinusitis and orbital cellulitis were not e

9 roducing ability of the clinical isolates in chronic rhinosinusitis and orbital cellulitis, and to lo

10 enic potential of these organisms in causing chronic rhinosinusitis and orbital cellulitis.

11 sted by adult-onset asthma, nasal polyposis, chronic rhinosinusitis, and aspirin sensitivity.

12 lyps, chronic obstructive pulmonary disease, chronic rhinosinusitis, and asthma.

13 atory tract diseases including otitis media, chronic rhinosinusitis, and exacerbations of both cystic

14 mucosal tissue homogenates in patients with chronic rhinosinusitis, and this effect was most promine

15 These features mimic essential aspects of chronic rhinosinusitis-associated olfactory loss, and il

16 Airway diseases such as chronic rhinosinusitis, asthma, and chronic obstructive

17 widespread prevalence of allergic, viral and chronic rhinosinusitis, but how the brain encodes and ma

18 urgical specimens derived from patients with chronic rhinosinusitis compared to control patients.

19 Allergic rhinitis (AR), chronic rhinosinusitis (CRS) and asthma often co-exist.

20 th chronic sinonasal inflammation, including chronic rhinosinusitis (CRS) and cystic fibrosis.

21 chanisms and immune pathways associated with chronic rhinosinusitis (CRS) are not fully understood.

22 nd mechanisms of activation in patients with chronic rhinosinusitis (CRS) are not known.

23 of antibiotic therapy is often initiated for chronic rhinosinusitis (CRS) based on symptomatology.

24 Asthma and chronic rhinosinusitis (CRS) both impair quality of life

25 It is increasingly recognized that chronic rhinosinusitis (CRS) comprises a spectrum of dif

26 lines provide composite criteria to evaluate chronic rhinosinusitis (CRS) control, taking into consid

27 Chronic rhinosinusitis (CRS) defines a group of disorder

28 Chronic rhinosinusitis (CRS) has a broad range of comorb

29 Chronic rhinosinusitis (CRS) has been known as a disease

30 Chronic rhinosinusitis (CRS) has been linked to the gram

31 LP protein and its function in patients with chronic rhinosinusitis (CRS) have not been fully explore

32 revalence of asthma and its association with chronic rhinosinusitis (CRS) have not been widely studie

33 Current clinical classifications of chronic rhinosinusitis (CRS) have weak prognostic utilit

34 s (EPOS) criteria to study the prevalence of chronic rhinosinusitis (CRS) in a general-population sam

35 host-microbial interactions in patients with chronic rhinosinusitis (CRS) in hopes of elucidating mec

36 Chronic rhinosinusitis (CRS) is a common condition in th

37 Chronic rhinosinusitis (CRS) is a common disease with st

38 Chronic rhinosinusitis (CRS) is a complex disease consis

39 Chronic rhinosinusitis (CRS) is a disease characterized

40 Chronic rhinosinusitis (CRS) is a frequent condition tha

41 Chronic rhinosinusitis (CRS) is a heterogeneous disease

42 Chronic rhinosinusitis (CRS) is a multifactorial disease

43 Chronic rhinosinusitis (CRS) is a prevalent condition wi

44 Chronic rhinosinusitis (CRS) is a prevalent multifactori

45 Chronic rhinosinusitis (CRS) is a troublesome, chronic i

46 Chronic rhinosinusitis (CRS) is an inflammation of the n

47 Chronic rhinosinusitis (CRS) is an inflammatory disease

48 Chronic rhinosinusitis (CRS) is an inflammatory disease

49 Chronic rhinosinusitis (CRS) is an inflammatory process

50 Patients with chronic rhinosinusitis (CRS) often have comorbid asthma.

51 Studies of the underlying cause or causes of chronic rhinosinusitis (CRS) over the past 20 or more ye

52 Recently, ILC2s enrichment was noted in chronic rhinosinusitis (CRS) patients; however, the role

53 The cause of chronic rhinosinusitis (CRS) remains unclear.

54 Although chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP)

55 ecretions, were collected from patients with chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP)

56 Chronic rhinosinusitis (CRS) without nasal polyps (CRSsN

57 luding eosinophilia, which is in contrast to chronic rhinosinusitis (CRS) without nasal polyps (NPs).

58 en postbronchodilator lung function, asthma, chronic rhinosinusitis (CRS), and atopy with age using a

59 in many mucosal diseases, including asthma, chronic rhinosinusitis (CRS), and eosinophilic esophagit

60 eased in nasal polyps (NPs) of patients with chronic rhinosinusitis (CRS), as well as in bronchoalveo

61 Despite the high prevalence and morbidity of chronic rhinosinusitis (CRS), little is known about the

62 nnaire items, we identified respondents with chronic rhinosinusitis (CRS), migraine headache, and fat

63 t-reported outcomes during the management of chronic rhinosinusitis (CRS), PROMs will play an essenti

64 nt algorithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS), respectively.

65 nt algorithms for allergic rhinitis (AR) and chronic rhinosinusitis (CRS).

66 immunoglobulin deficiencies in patients with chronic rhinosinusitis (CRS).

67 of the sample with subjects with asthma and chronic rhinosinusitis (CRS).

68 of the fibrinolytic system in patients with chronic rhinosinusitis (CRS).

69 sion of coagulation factors in patients with chronic rhinosinusitis (CRS).

70 important roles in inflammatory processes in chronic rhinosinusitis (CRS).

71 oke (CS) plays a role in the exacerbation of chronic rhinosinusitis (CRS); however, the mechanism for

72 lated comorbidities are discussed: rhinitis, chronic rhinosinusitis, gastroesophageal reflux, obstruc

73 Invasive disease includes indolent chronic rhinosinusitis, granulomatous fungal sinusitis,

74 Chronic rhinosinusitis has a significant impact on patie

75 e relationship between allergic rhinitis and chronic rhinosinusitis has been assessed in a number of

76 We found that patients with chronic rhinosinusitis have elevated glucose concentrati

77 lly transmitted infections, cystic fibrosis, chronic rhinosinusitis, inflammatory bowel disease, and

78 Chronic rhinosinusitis is a consistent feature of the au

79 The pathogenesis of chronic rhinosinusitis is a growing area of interest, bu

80 es of use included acute inflammation (n=6), chronic rhinosinusitis (n=2), and allergic rhinitis (n=2

81 ory secretions in pathologic states, such as chronic rhinosinusitis or hyperglycemia, promotes tonic

82 underlying disease (asthma, nasal polyps or chronic rhinosinusitis, or both), as well as on the meth

83 Chronic rhinosinusitis patients with 1 CF mutation were

84 ce of symptoms of asthma, allergic rhinitis, chronic rhinosinusitis, smoking status, and history of N

85 ns to NSAIDs was higher in participants with chronic rhinosinusitis symptoms (Odds Ratio 2.12; 95%CI

86 Among patients with nasal polyps and chronic rhinosinusitis, the prevalence was 9.69% (95% CI

87 polyp specimens from patients with AERD and chronic rhinosinusitis were analyzed by using quantitati

88 rty (240) patients with clinical features of chronic rhinosinusitis were examined; patients with firs

89 Chronic rhinosinusitis with nasal polyposis (CRSwNP) in

90 A role for mast cells is suggested in chronic rhinosinusitis with nasal polyposis (CRSwNP), wh

91 d with uncinate tissue (UT) of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and th

92 A number of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) are re

93 Chronic rhinosinusitis with nasal polyps (CRSwNP) is a c

94 Chronic rhinosinusitis with nasal polyps (CRSwNP) is ass

95 Chronic rhinosinusitis with nasal polyps (CRSwNP) is ass

96 Although chronic rhinosinusitis with nasal polyps (CRSwNP) is cha

97 n of PD-1 and its ligands PD-L1 and PD-L2 in chronic rhinosinusitis with nasal polyps (CRSwNP) is poo

98 osinusitis without nasal polyps (CRSsNP) and chronic rhinosinusitis with nasal polyps (CRSwNP) using

99 hinosinusitis without nasal polyps (CRSsNP), chronic rhinosinusitis with nasal polyps (CRSwNP), and a

100 lucocorticoid receptor (GR) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

101 Chronic rhinosinusitis with nasal polyps (NP) and allerg

102 hronic airway inflammatory diseases, such as chronic rhinosinusitis with nasal polyps and asthma, sho

103 ated respiratory disease is a severe form of chronic rhinosinusitis with nasal polyps in which nearly

104 Chronic rhinosinusitis with nasal polyps is associated w

105 Chronic rhinosinusitis with nasal polyps is characterize

106 ct the host from infections in patients with chronic rhinosinusitis with nasal polyps.

107 a range of premorbid medical conditions for chronic rhinosinusitis without nasal polyps (CRSsNP) and

108 of IL-19, at lower extent, in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) in

109 luids (NLFs) from controls and patients with chronic rhinosinusitis without nasal polyps (CRSsNP), ch

110 is with nasal polyps (CRSwNP) and those with chronic rhinosinusitis without nasal polyps (CRSsNP; P <

111 surgery from control subjects, patients with chronic rhinosinusitis without nasal polyps, and patient